MD Mednax Earnings and EPS analysis

Relative Growth: Rel. Growth: 56

Relative Strength: Rel. Strength: 90

Relative Valuation: Rel. Valuation: 96

Relative Profitability: Rel. Profitability: 82

EPS in 2025 (TTM): $1.93

Last Report Period Date: Sep 30, 2025

As of November 2025, MD's trailing twelve months (TTM) EPS stands at $1.93, according to the latest financial reports. In 2024, the company recorded an earnings per share (EPS) of -$1.19, which represents a decrease compared to its EPS of -$0.73 in 2023. MD reported an EPS of $0.85 for the quarterly report ending on Sep 30, 2025.

MD earnings history

Historical annual and quarterly earnings per share (EPS) data for Mednax

EPS (TTM)

$1.93

EPS Growth YoY (Quarterly)

269.6%

EPS (Quarterly)

$0.85

EPS Growth (Quarterly)

84.8%

For 2024, Mednax's EPS was -$1.19, a decrease of 63% from -$0.73 in 2023. For the quarter ending Sep 30, 2025, the EPS was $0.85, showing a 269.6% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of September 2025 is $1.93. In 2023, the annual EPS was -$0.73, showing a decrease of 192.4% from 2022.

MD EPS growth

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

269.6%

EPS growth YoY

-63%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Mednax has recorded an increase in EPS of 269.6% over the last 12 months (YoY, quarterly).

MD Earnings Waterfall

Breakdown of revenue, profit and net income for Mednax

MD Earnings vs Peers

What are the earnings of MD compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
CYH Community Health Systems Inc	1.52	-282.4%	N/A	N/A
MD Mednax Inc	11.3	-63%	N/A	N/A
UHS Universal Health Services Inc	11.75	65.8%	12.7%	13.4%
THC Tenet Healthcare Corp	13.8	449.4%	56.9%	N/A

All data is based on quarterly TTM periods, unless otherwise specified.